Issue: May 2017
March 29, 2017
4 min read
Save

NSAIDs increase early risk for out-of-hospital cardiac arrest

Issue: May 2017

The use of nonsteroidal anti-inflammatory drugs was associated with out-of-hospital cardiac arrest, with an increased risk in ibuprofen and diclofenac users, according to published data.

Perspective from Gregory Lane, DACM, LAc

“Over the last decade, evidence of a [CV] risk associated with use of NSAIDs has emerged,” Kathrine B. Sondergaard, MD, of the department of cardiology at Copenhagen University Hospital Gentofte, Denmark, and colleagues wrote. “The selective COX-2 inhibitors, and to a lesser extent the nonselective NSAIDs, have been associated with [CV] adverse events, such as [MI], stroke and [HF] in randomized and observational studies. Cardiac arrest is the ultimate adverse drug event, and though it is closely linked to ischemic disease and [CV] morbidity, the association between NSAIDs and cardiac arrest has never been investigated.”

Sondergaard and colleagues evaluated all patients with out-of-hospital cardiac arrest from the Danish Cardiac Arrest Registry an identified NSAID use 30 days before the event. The NSAIDs analyzed were diclofenac, naproxen and ibuprofen, as well as the COX-2 inhibitors rofecoxib and celecoxib.

In the registry, 28,947 out-of-hospital cardiac arrests were recorded, with 3,376 patients being treated with an NSAID up to 30 days before the event, the researchers wrote.

The most common NSAIDs were ibuprofen (51%) and diclofenac (21.8%).

Diclofenac (OR = 1.5; 95% CI, 1.23-1.82) and ibuprofen (OR = 1.31; 95% CI ,1.14-1.51) were associated with a significantly increased risk for out-of-hospital cardiac arrest, according to the findings. Characterized by fewer events, naproxen (OR = 1.29; 95% CI, 0.77-2.16), celecoxib (OR = 1.13; 95% CI, 0.74-1.7) and rofecoxib (OR= 1.28; 95% CI, 0.74-1.7) did not confer significantly increased risk for cardiac arrest.

“Our findings support the accumulating evidence of an unfavorable [CV] risk profile associated with use of the nonselective NSAIDs,” the researchers wrote. “This calls for special awareness in order to balance risks against benefits in treatment with NSAIDs.” – by Cassie Homer

Disclosure: The researchers report no relevant financial disclosures.